KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Tax Rate (2017 - 2025)

Historic Tax Rate for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to 16.79%.

  • Biomarin Pharmaceutical's Tax Rate fell 378900.0% to 16.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.39%, marking a year-over-year increase of 57200.0%. This contributed to the annual value of 21.21% for FY2024, which is 101200.0% up from last year.
  • According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Tax Rate is 16.79%, which was down 378900.0% from 19.25% recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Tax Rate ranged from a high of 98.58% in Q4 2022 and a low of 249.37% during Q3 2022
  • For the 5-year period, Biomarin Pharmaceutical's Tax Rate averaged around 4.39%, with its median value being 18.89% (2024).
  • In the last 5 years, Biomarin Pharmaceutical's Tax Rate crashed by -13610800bps in 2021 and then soared by 2524700bps in 2023.
  • Over the past 5 years, Biomarin Pharmaceutical's Tax Rate (Quarter) stood at 13.03% in 2021, then soared by 656bps to 98.58% in 2022, then tumbled by -106bps to 5.42% in 2023, then surged by 586bps to 26.35% in 2024, then plummeted by -164bps to 16.79% in 2025.
  • Its Tax Rate was 16.79% in Q3 2025, compared to 19.25% in Q2 2025 and 22.01% in Q1 2025.